Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences (OACC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
oacc · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Oaktree Acquisition Corp. III Life Sciences (OACC) measures how much investors pay for each dollar of the company's trailing earnings. OACC's current PE ratio of 29.16x is calculated by dividing its stock price of $10.65 by its TTM earnings per share of $0.37. +4.6% elevated vs 5Y avg 27.9x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2024 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Oaktree Acquisition Corp. III Life SciencesYou OACC | $262M | 29.16x | -89.4% | $0.37 |
 Artius II Acquisition Inc. Class A Ordinary Shares AACB | $290M | 1462.22x | +429.3% | $0.01 |
 Cartesian Growth Corporation III CGCT | $328M | 30.14x | -89.1% | $0.34 |
 Copley Acquisition Corp COPL | $247M | 44.14x | -84.0% | $0.23 |
 FACT II Acquisition Corp FACT | $260M | 38.36x | -86.1% | $0.27 |
 M3-Brigade Acquisition V Corp. Class A Ordinary shares MBAV | $388M | 52.89x | -80.9% | $0.20 |
 Mountain Lake Acquisition Corp. MLAC | $219M | 29.89x | -89.2% | $0.35 |
Industry Average 6 peers with valid PE | — | 276.27x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 27.87x | $0.38 | -100.0% | |
2024-12-31 FY2024 | — | $0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Oaktree Acquisition Corp. III Life Sciences (OACC) measures how much investors pay for each dollar of the company's trailing earnings. OACC's current PE ratio of 29.16x is calculated by dividing its stock price of $10.65 by its TTM earnings per share of $0.37.
Frequently asked questions
OACC pe ratio · 6 questionsOACC's current PE ratio is 29.16x as of 2026-06-08, based on a stock price of $10.65 and TTM EPS of $0.37. Data sourced from Financial Modeling Prep via OACC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Oaktree Acquisition Corp. III Life Sciences SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08